We utilized single-cell genomics to characterize a T-ALL patient treated on COG AALL0434 with a poor clinical outcome despite favorable genomic features, identifying a STAT1-mediated interferon-related transcriptional signature and an inflammatory microenvironment that was associated with sensitivity to small molecule JAK-inhibition.

This content is only available as a PDF.

Article PDF first page preview

Article PDF first page preview
You do not currently have access to this content.
Sign in via your Institution